Deficiencies and shortfalls in the supply of human organs for
transplantation and human tissue for research generate policy
dilemmas across the world and have often given rise to major and
deleterious controversies, such as those relating to organ and
tissue retention practices following post-mortem examination. They
also create an environment in which illegitimate commercial
activities flourish. At the same time, patients are denied the
therapy they desperately require and researchers are impeded from
carrying out vital work into the causes of, and efficacious
treatments for, major illnesses and diseases. David Price sets out
a clear and integrated legal and policy framework which emanates
from the tissue source but protects the interests of donors and
relevant professionals through tailored property entitlements, but
without presupposing rights to trade in 'original' materials.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!